Drug intelligence / Profile preview

EVA-001

Development stage
Phase 2
Lead developer
EVASTEM
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intraarticular
01

Overview

EVA-001 is an autologous cell therapy product composed of expanded synovial mesenchymal stem cells (MSCs) intended for the treatment of articular cartilage defects in the knee. Developed by the Japanese biotechnology company EVASTEM, the treatment process involves harvesting a small amount of synovial tissue from the patient, isolating the MSCs, and expanding them in a specialized culture facility. The expanded cells are then transplanted back into the patient's cartilage defect site. The therapeutic effect is mediated by the ability of synovial MSCs to differentiate into chondrocytes and their high proliferative capacity, which facilitates the regeneration of hyaline-like cartilage and improves joint function. This approach aims to restore the structural integrity of the joint surface and potentially prevent the progression of osteoarthritis.

Other names
Autologous synovial mesenchymal stem cells

Beyond the preview

Go deeper on EVA-001.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EVA-001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call